• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过组蛋白修饰谱对乳腺癌进行新型亚型分类及风险评估

A novel subtype classification and risk of breast cancer by histone modification profiling.

作者信息

Chen Xiaohua, Hu Hanyang, He Lin, Yu Xueyuan, Liu Xiangyu, Zhong Rong, Shu Maoguo

机构信息

Departmemt of Plastic, Aesthetic and Craniofacial Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.

Department of Laboratory Medicine, No.161 Hospital of PLA, Wuhan, 430010, China.

出版信息

Breast Cancer Res Treat. 2016 Jun;157(2):267-279. doi: 10.1007/s10549-016-3826-8. Epub 2016 May 13.

DOI:10.1007/s10549-016-3826-8
PMID:27178334
Abstract

Breast cancer has been classified into several intrinsic molecular subtypes on the basis of genetic and epigenetic factors. However, knowledge about histone modifications that contribute to the classification and development of biologically distinct breast cancer subtypes remains limited. Here we compared the genome-wide binding patterns of H3K4me3 and H3K27me3 between human mammary epithelial cells and three breast cancer cell lines representing the luminal, HER2, and basal subtypes. We characterized thousands of unique binding events as well as bivalent chromatin signatures unique to each cancer subtype, which were involved in different epigenetic regulation programs and signaling pathways in breast cancer progression. Genes linked to the unique histone mark features exhibited subtype-specific expression patterns, both in cancer cell lines and primary tumors, some of which were confirmed by qPCR in our primary cancer samples. Finally, histone mark-based gene classifiers were significantly correlated with relapse-free survival outcomes in patients. In summary, we have provided a valuable resource for the identification of novel biomarkers of subtype classification and clinical prognosis evaluation in breast cancers.

摘要

基于遗传和表观遗传因素,乳腺癌已被分为几种内在分子亚型。然而,关于有助于生物学上不同的乳腺癌亚型分类和发展的组蛋白修饰的知识仍然有限。在这里,我们比较了人乳腺上皮细胞与代表管腔型、HER2型和基底型亚型的三种乳腺癌细胞系之间H3K4me3和H3K27me3的全基因组结合模式。我们鉴定了数千个独特的结合事件以及每种癌症亚型特有的二价染色质特征,这些特征参与了乳腺癌进展中不同的表观遗传调控程序和信号通路。与独特组蛋白标记特征相关的基因在癌细胞系和原发性肿瘤中均表现出亚型特异性表达模式,其中一些在我们的原发性癌症样本中通过qPCR得到了证实。最后,基于组蛋白标记的基因分类器与患者的无复发生存结果显著相关。总之,我们为鉴定乳腺癌亚型分类和临床预后评估的新型生物标志物提供了宝贵资源。

相似文献

1
A novel subtype classification and risk of breast cancer by histone modification profiling.通过组蛋白修饰谱对乳腺癌进行新型亚型分类及风险评估
Breast Cancer Res Treat. 2016 Jun;157(2):267-279. doi: 10.1007/s10549-016-3826-8. Epub 2016 May 13.
2
Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes.乳腺癌细胞系中的组蛋白修饰谱分析突出了亚型之间的共性和差异。
BMC Genomics. 2018 Feb 20;19(1):150. doi: 10.1186/s12864-018-4533-0.
3
Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.比较表观遗传学分析揭示了乳腺癌亚型中致癌途径激活的不同模式。
Hum Mol Genet. 2014 Oct 15;23(20):5378-93. doi: 10.1093/hmg/ddu256. Epub 2014 May 27.
4
Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.胶质母细胞瘤干细胞中H3K4me3和H3K27me3谱的全局分析以及SLC17A7作为双价肿瘤抑制基因的鉴定。
Oncotarget. 2015 Mar 10;6(7):5369-81. doi: 10.18632/oncotarget.3030.
5
The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.组蛋白伴侣HJURP是腔面A型乳腺癌一种新的独立预后标志物。
Mol Oncol. 2015 Mar;9(3):657-74. doi: 10.1016/j.molonc.2014.11.002. Epub 2014 Nov 20.
6
Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.分析 HER2+乳腺癌细胞系中 H3K4me3 和 H3K27me3 双价启动子,发现其随雌激素受体状态的变化而变化,并与基因表达显著相关。
BMC Med Genomics. 2020 Jul 3;13(1):92. doi: 10.1186/s12920-020-00749-2.
7
Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer.生物过程的全面分析揭示了乳腺癌的两种主要预后亚型。
Tumour Biol. 2016 Mar;37(3):3365-70. doi: 10.1007/s13277-015-4173-9. Epub 2015 Oct 7.
8
Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.竞争性内源性RNA网络分析确定了不同乳腺癌亚型中的关键基因。
Oncotarget. 2017 Feb 7;8(6):10171-10184. doi: 10.18632/oncotarget.14361.
9
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.不同乳腺上皮细胞类型的微小RNA特征与其基因表达和表观遗传图谱的整合。
Breast Cancer Res. 2015 Jun 18;17(1):85. doi: 10.1186/s13058-015-0585-0.
10
H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes.乳腺肿瘤分子亚型中的H3K4乙酰化、H3K9乙酰化和H3K27甲基化
Epigenomics. 2016 Jul;8(7):909-24. doi: 10.2217/epi-2016-0015. Epub 2016 Jul 18.

引用本文的文献

1
Decoding the Epigenome of Breast Cancer.解读乳腺癌的表观基因组。
Int J Mol Sci. 2025 Mar 13;26(6):2605. doi: 10.3390/ijms26062605.
2
The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.美国中西部乳腺癌队列的突变景观揭示了特定亚型的癌症驱动因素和预后标志物。
Hum Genomics. 2023 Jul 15;17(1):64. doi: 10.1186/s40246-023-00511-6.
3
Multimodal ultrasound features of breast cancers: correlation with molecular subtypes.乳腺癌的多模态超声特征:与分子亚型的相关性。
BMC Med Imaging. 2023 Apr 17;23(1):57. doi: 10.1186/s12880-023-00999-3.
4
Histone 3 Lysine 27 Trimethylation Signature in Breast Cancer.乳腺癌中组蛋白 3 赖氨酸 27 三甲基化特征。
Int J Mol Sci. 2021 Nov 27;22(23):12853. doi: 10.3390/ijms222312853.
5
Toward reproducible, scalable, and robust data analysis across multiplex tissue imaging platforms.实现多重组织成像平台上可重复、可扩展和稳健的数据分析。
Cell Rep Methods. 2021 Aug 23;1(4). doi: 10.1016/j.crmeth.2021.100053. Epub 2021 Jul 23.
6
Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.分析 HER2+乳腺癌细胞系中 H3K4me3 和 H3K27me3 双价启动子,发现其随雌激素受体状态的变化而变化,并与基因表达显著相关。
BMC Med Genomics. 2020 Jul 3;13(1):92. doi: 10.1186/s12920-020-00749-2.
7
Characterization of histone modification patterns and prediction of novel promoters using functional principal component analysis.基于功能主成分分析的组蛋白修饰模式表征及新启动子预测。
PLoS One. 2020 May 27;15(5):e0233630. doi: 10.1371/journal.pone.0233630. eCollection 2020.
8
Analysis of opposing histone modifications H3K4me3 and H3K27me3 reveals candidate diagnostic biomarkers for TNBC and gene set prediction combination.分析拮抗组蛋白修饰 H3K4me3 和 H3K27me3 可揭示 TNBC 的候选诊断生物标志物和基因集预测组合。
BMB Rep. 2020 May;53(5):266-271. doi: 10.5483/BMBRep.2020.53.5.045.
9
Expression and potential prognostic value of histone family gene signature in breast cancer.组蛋白家族基因特征在乳腺癌中的表达及潜在预后价值
Exp Ther Med. 2019 Dec;18(6):4893-4903. doi: 10.3892/etm.2019.8131. Epub 2019 Oct 25.
10
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.微小 RNA 与表观遗传学策略逆转乳腺癌。
Cells. 2019 Oct 8;8(10):1214. doi: 10.3390/cells8101214.